Cellectis is a biotech company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART).
Cellectis – gene-editing
Tag Archives: Laurent Arthaud
TxCell – antigen-specific Type 1 Treg cells
TxCell is a biotech company developing innovative and personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for autoimmune diseases and severe chronic inflammatory diseases.
